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 Dengue  fever (DF) is  an  acute  febrile  disease  caused  by  dengue  virus,  which  was 
re-emerged in tropical regions in the past 20 years. The numbers of imported DF were 6 
to 44 per year in the recent Japan. We report a Japanese member of non-governmental 
organization (NGO) with dengue fever (DF). The patient developed sudden onset of 
high fever after returning to Japan, followed by rash and thrombocytopenia. DF was 
confirmed by isolation of dengue virus from serum, a positive reverse-transcriptase 
polymerase chain reaction (RT-PCR) test, and a high titer of IgM antibody to dengue 
virus. Dengue virus infection should be included in the differential diagnosis of the 
patients, developing high fever, skin rash, and thrombocytopenia after returning from 
endemic area.
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CASE REPORT
 A 25-year-old Japanese woman, as a member 
of non-governmental organization (NGO), 
stayed in the East Timor (ET) for 10 days in 
February 2002. The patient developed an acute 
fever (temperature; 40℃) without cough, 
dyspnea, sore  throat,  or  diarrhea,  just 
returning from ET. She was treated with anti-
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inflammatory drugs and anti-biotics in a local 
hospital. She continued to present with fever, 
and furthermore had diarrhea and vomiting 
for 2 days, despite of these treatments. On the 
6 day after the onset of fever, the patient 
showed an erythematous rash with itching, 
and was admitted to Yamagata University 
Hospital for further evaluation. 
　Physical  examination  revealed  multiple 
erythema with itching on extremities without 
edema, purpura, hepatosplenomegaly, or swell-
ing of lymph nodes.  She had anorexia and mild 
fever (temperature; 37.3℃).  The laboratory 
findings at that time included: hemoglobin 
14.5 g /dl, hematocrit 43%, white blood cell 
(WBC) count 2,450/mm3 with 9 % atypical 
lymphocytes, platelet count 60,000/mm3, total 
serum protein 6.6 g /dl, total serum albumin 
3.8 g /dl, alanine aminotransferase (ALT) 37 IU/
 liter, asparate aminotransferase (AST) 59 IU/ 
liter, lactate dehydrogenase (LDH) 654 IU/ 
liter, alkaline phosphatase 51 IU/ liter, total 
serum bilirubin 0.4 mg/dl, serum creatinin 0.6 
mg/dl, serum blood urea nitrogen 3 mg /dl, and 
c-reactive protein 0.1 mg /dl. Examination of 
both influenza A and B antigens from nasal 
mucosa was negative. Urinary analysis was 
normal. Prothrombin time, activated partial 
thrombin time, fibrinogen, and fibrin / fibrino-
gen degradation products, were all within 
normal  limits.  Extensive  examination  of 
peripheral blood films showed no evidence of 
any forms of malaria, but atypical lymphocytes 
(Fig. 1). Therefore, in the admission day, we 
considered the patient as having the possibility 
of dengue fever (DF), since she was bitten 
several times by the mosquitoes in the ET, a 
dengue epidemic area, and presented with 
leukocytopenia, thrombocytopenia, rash, and 
biphasic fever, considered to be the most 
characteristic features of classic dengue fever1). 
The serum samples on disease days 7 and 8 
were quickly sent to the Department of 
Virology 1, National Institute of Infectious 
Disease, Japan (NIID) for the laboratory 
diagnosis of dengue virus infection. At the next 
day, the NIID reported that the patient had an 
anti-flavivirus IgM antibody by the IgM-
capture enzyme-linked immunosorbent assay 
(ELISA) and immunochromatographic test 
(Rapid Kit)2) (Table 1). Further laboratory 
investigations by reverse transcriptase-po-
lymerase chain reaction (RT-PCR), hemaggluti-
nation inhibition (HI) test, and virus isolation, 
demonstrated that the patient was infected 
with type 2 dengue virus 2),3). Within hospital 
day 3, the patient had a complete clinical 
recovery, and a platelet count of 155,000/mm3 
and WBC count 6,440/mm3 with 12% atypical 
lymphocytes without therapy.  Repeated blood 
and stool culture examination showed no 
evidence  of  bacterial  infection,  including 
Salmonella typhi. The patient was discharged 
on hospital day 4. A typical lymphocytes 
disappeared within 25 days of the onset of DF.
 
Tajima, Harada, Karube, Yamamoto, Honma, Hiroshima, Shimizu, Yamamoto, Katou, Akiba, Yamada, Kurane, Kato
 Table 1.  Anti-IgM antibody to dengue virus
Day 8Day 7Test
Not done+Rapid Kit
13.9(+)10.7(+)IgM-capture ELISA test
　Fig. 1. 
Atypical lymphocytes in peripheral blood on 
Day 7.
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DISCUSSION
 We diagnosed a patient with imported DF on 
the first hospital day, and the patient recovered 
from DF without specific therapy.  
　Dengue virus infection, which one of the 
most important infectious disease in tropical 
areas of the world, are subclinical or manifest 
as DF or dengue hemorrhagic fever (DHF)1),4). 
Dengue infections are most prevalent in 
Southeast Asia, where all four serotypes 1 to 4 
are continuously present 5). Dengue viruses are 
transmitted by infected mosquitoes, Aedes 
aegypti. In most cases, DF is a self-limited 
syndrome of biphasic fever, headache, myalgia, 
lymphadenopathy, and rash accompanied by 
leukocytopenia and thrombocytopenia. Symp-
toms resolve after 2-7 days. Some patients 
have a risk of progressive development into 
DHF, a life-threatening syndrome, character-
ized by abnormalities in hemostasis and 
increased vascular permeability 1),6),7),8),9). In this 
case, clinical symptoms, such as rash and 
biphasic fever are typical of DF, but nausea and 
vomiting are uncommon to it. The present 
patient also showed typical laboratory findings 
in DF, including leukopenia, thrombocytopenia, 
and liver dysfunction1). With these typical 
symptoms, findings, and history of bitten by 
the mosquitoes in dengue epidemic area, we 
could consider this patient to have DF. In the 
present study, atypical lymphocytosis and 
monocytosis on peripheral smear reached its 
peak on day 10 after fever onset, and 
disappeared gradually. A recent study has 
shown that the leukocyte profiles of DF reveals 
the CD4/CD8 ratio inversion, monocytosis, and 
atypical lymphocytosis1),10),11). Thus, repeated 
examinations of peripheral smear may be 
useful and essential, not only to exclude 
malaria infections, but also to make a correct 
diagnosis of DF.
　Dengue virus infection is confirmed by the 
laboratory tests3). In the present case, a 
diagnosis of DF was confirmed by the positive 
results of an IgM antibody, and later by virus 
isolation from serum sample of disease day 7 
that yielded a dengue 2 strain genome. The 
previous studies revealed that viruses are 
isolated from serum samples collected before 
fever subsides 5),12). In this case, her fever 
resolved within disease day 9. Thus, for 
isolation of virus and confirmation of dengue 
strain, it is important to preserve serum 
samples from febrile patients who have just 
returned from dengue epidemic areas.
　The treatment and management of DF, 
whose pathogenesis is not clearly understood, 
are  essentially  supportive  and  symptom-
atic1),4),13). For control of fever, anti-inflamma-
tory drugs, especially including salicylic acid, 
should be avoided to prevent hemorrhagic 
tendency and acidosis1). The present patient 
already had been treated with anti-inflamma-
tory drugs and anti-biotics in a local hospital 
before making a definite diagnosis. Therefore, 
the recognition of DF in unknown febrile 
illness in a patient returning from an endemic 
area to Japan is important for clinicians to 
avoid an inappropriate therapy and exami-
nation. DF is a febrile imported disease worthy 
of more attention from the medical community 
in a distinct Japan12),14). This is the first case of 
DF in Yamagata prefecture.
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